• P. Neeraja Department of Pharmacy, University College of Technology, Osmania University, Hyderabad, Telangana 500007, India
  • T. Parthasarathy Department of Chemistry, Osmania University, Hyderabad, Telangana 500007, India
  • M. Sudhakar Department of pharmaceutics, Malla Reddy College of Pharmacy, Maisammaguda, Secunderabad, Telangana 500014, India




Pseudomonas aeruginosa, Anticancer activity, Bacterial proteins, Optimized media, Biomass and asparagine-proline broth


Objective: Microorganisms, especially bacteria and its proteins have proven to be potential anti-cancer agents as they selectively attack the tumor cells or tumor micro-environments. The extract of Pseudomonas aeruginosa found to contain proteins that have shown promising anticancer activity. In this work, it was attempted to increase the biomass and trigger the total protein fraction of Pseudomonas aeruginosa (MTCC 2453).

Methods: The organism was cultivated in three different such as Luria-Bertani (LB) broth, minimal medium9 (M9), super broth medium (SB) and asparagine-proline (AP) broth. Asparagine proline broth was selected as it has shown high cell growth rate. The media was further optimized by the addition of NaHCO3 and copper sulphate to trigger the protein production. Optimized Aspergine proline broth has achieved highest cell biomass. After the shake flask culture, the overnight grown culture in optimized AP medium was further grown in a 5 L bioreactor by fed-batch cultivation to achieve higher cell densities.

Results: The highest protein production was achieved at 40 ° C. Highest biomass and protein content was observed at pH 8 while lowest biomass was produced at pH 2. A gradual increase in biomass content observed from 12 h towards to 48 h.

Conclusion: High biomass and proteins content and of Pseudomonas aeruginosa (MTCC 2453) can be produced in optimized asparagine-proline broth. Further the extract is purified to produce novel anti-cancer proteins.


Download data is not yet available.


Bernardes N, Seruca R, Chakrabarty AM, Fialho AM. Microbial-based therapy of cancer: current progress and future prospects. Bioengineered Bug 2010;1:178–90.

Fialho AM, Bernardes N, Chakrabarty AM. Recent patents on live bacteria and their products as potential anticancer agents. Recent Pat Anti-Cancer Drug Discovery 2012;7:31–55.

Bernardes N, Chakrabarty AM, Fialho AM. Engineering of bacterial strains and their products for cancer therapy. Appl Microbiol Biotechnol 2013;97:5189–99.

Almas Okassov, Armen Nersesyan, Sakae Kitada, Alexander Ilin. Parasporins as new natural anticancer agents: a review. J BUON 2015;20:5-16.

Michio ohba, Eiichi mizuki, Akiko uemori. Parasporin, a new anticancer protein group from Bacillus thuringiensis. Anticancer Res 2009;29:427-34.

Baron C, Ocallaghan D, Lanka E. Bacterial secrets of secretion. Mol Microbiol 2002;43:1359–65.

Llosa M, Gomis-Ruth FX, Coll M, de la Cruz F. Bacterial conjugation: a two-step mechanism for DNA transport. Mol Microbiol 2002;45:1–8.

Puri RK. Development of a recombinant interleukin 4 Pseudomonas exotoxin for therapy of glioblastoma. Toxicol Pathol 1999;27:53-7.

Tomasz M Karpiński, Anna K Szkaradkiewicz. Anticancer peptides from bacteria. Bangladesh J Pharmacol 2013;8:343-8.

Charlotte F Michelsen, Helle Jensen, Vincent J Venditto, Rosanna C Hennessy. Peter stougaard bioactivities by a crude extract from the greenlandic Pseudomonas sp. In5 involves the nonribosomal peptides, nunamycin, and nunapeptin. Peer J 2015;3:e1476.

Stover KC, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1: an opportunistic pathogen. Nature 2000; 406:959-64.

Ding Z, Peng L, Chen Y, Zhang L, Gu Z, Shi G, et al. Production and characterization of thermostable laccase from the mushroom, Ganoderma lucidum using submerged fermentation. Afr J Microbiol Res 2012;6:1147–57.

Shah AH, Kamboh AA, Rajput N, Korejo NA. Optimization of physicochemical conditions for the growth of Pasteurella multocida under in vitro. J Agric Soc Sci 2008;4:176-9.

Khusro A, Sankari D. Synthesis and estimation of total extracellular protein content in Bacillus subtilis under mild stress condition of certain antimicrobials. Asian J Pharm Clin Res 2014;8:88-90.

Patyar S, Joshi R, Prasad Byrav DS, Prakash A, Medhi B, Das BK. Bacteria in cancer therapy: a novel experimental strategy. J Biomed Sci 2010;17:21.

Dolores Vazquez-Rivera, Omar Gonzalez, Jaquelina Guzman-Rodriguez, Alma L Dlaz-Perez, Ochoa-Zarzosa, Jose Lopez-Bucio, et al. Cytotoxicity of cyclodipeptides from Pseudomonas aeruginosa PAO1 leads to apoptosis in human cancer cell lines. Biomed Res Int 2015. http://dx.doi.org/10.1155/2015/ 197608.

Swati Jain, Ponmariappan S, Richa Sijoria, Goel AK, Om Kumar, Lokendra Singh. Optimization of a simple method for the high-yield production of recombinant bont/b light chain protein in E. coli hetero locus host system. J Biotechnol Lett 2012;3:20-7.

Elsayed MA, Hassan MM, Elshafei AM, Haroun BM, Othman AM. Optimization of cultural and nutritional parameters for the production of laccase by Pleurotus ostreatus ARC280. Br Biotechnol J 2012;2:115–32.

Praveesh BV, Soniyamby AR, Mariappan C, Kavithakumari P, Palaniswamy M. Production of biosurfactant using cashew nut shell liquid as the carbon source from Pseudomonas aeruginosa MTCC 424. Global J Biotechnol Biochem 2010;5:216-9.

Kim HO, Lim JM, Joo JH, Kim SW, Hwang HJ, Choi JW, et al. Optimization of submerged culture condition for the production of mycelial biomass and exopolysaccharides by Agrocybe cylindracea. Bioresour Technol 2005;96:1175-82.

Gupta R, Gigras P, Mohapatra H, Goswami VK, Chauhan B. Microbial α-amylases: a biotechnological prospective. Process Biochem 2003;38:1599–616.

Promita D, Saimon Ahmad T, Kaniz M, Palash Kumar S, Abu Sayem SM. Production and partial characterization of extracellular amylase enzyme from Bacillus amyloliquefaciens P-001. SpringerPlus 2013;2:154.



How to Cite

Neeraja, P., T. Parthasarathy, and M. Sudhakar. “EVALUATION OF DIFFERENT CULTURE MEDIA FOR ENHANCED PRODUCTION OF PSEUDOMONAS AERUGINOSA (MTCC NO 2453) BIOMASS AND ITS PROTEINS”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 11, Nov. 2016, pp. 120-3, doi:10.22159/ijpps.2016v8i11.13809.



Original Article(s)